These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 7417890)
1. Estrogen receptor status in breast cancer. Wright CJ Can J Surg; 1980 Jul; 23(4):316-7. PubMed ID: 7417890 [TBL] [Abstract][Full Text] [Related]
2. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer. Paradiso A; Tommasi S; Mangia A; Lorusso V; Simone G; De Lena M Cancer Res; 1990 May; 50(10):2958-62. PubMed ID: 2334898 [TBL] [Abstract][Full Text] [Related]
3. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer. Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661 [TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046 [TBL] [Abstract][Full Text] [Related]
5. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477 [TBL] [Abstract][Full Text] [Related]
6. International comparisons concerning breast cancer and steroid receptors. Matsumoto K; Sakamoto G; Nomura Y Anticancer Res; 1986; 6(4):621-4. PubMed ID: 3752942 [TBL] [Abstract][Full Text] [Related]
7. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors. Keshgegian AA Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Rosenberg LU; Einarsdóttir K; Friman EI; Wedrén S; Dickman PW; Hall P; Magnusson C Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2482-8. PubMed ID: 17164374 [TBL] [Abstract][Full Text] [Related]
9. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. Honma N; Horii R; Iwase T; Saji S; Younes M; Takubo K; Matsuura M; Ito Y; Akiyama F; Sakamoto G J Clin Oncol; 2008 Aug; 26(22):3727-34. PubMed ID: 18669459 [TBL] [Abstract][Full Text] [Related]
10. Steroid receptors in breast cancer. Desombre ER Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047 [TBL] [Abstract][Full Text] [Related]
11. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays. Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B; J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359 [TBL] [Abstract][Full Text] [Related]
12. Impact of metastatic estrogen receptor and progesterone receptor status on survival. Lower EE; Glass EL; Bradley DA; Blau R; Heffelfinger S Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528 [TBL] [Abstract][Full Text] [Related]
13. Primary hormonal therapy of advanced breast cancer with megestrol acetate: predictive value of estrogen receptor and progesterone receptor levels. Bonomi P; Johnson P; Anderson K; Wolter J; Bunting N; Strauss A; Roseman D; Shorey W; Economou S Semin Oncol; 1985 Mar; 12(1 Suppl 1):48-54. PubMed ID: 3975653 [TBL] [Abstract][Full Text] [Related]
14. Hormone receptors and Japanese breast cancer. Matsumoto K; Kitamura Y; Sugano H Acta Pathol Jpn; 1982; 32 Suppl 1():145-54. PubMed ID: 6764994 [TBL] [Abstract][Full Text] [Related]
15. Steroid hormone receptors in the management of human breast cancer. Knight WA; Osborne CK; Yochmowitz MG; McGuire WL Ann Clin Res; 1980 Oct; 12(5):202-7. PubMed ID: 7015982 [TBL] [Abstract][Full Text] [Related]
16. [Place of hormone receptor determination in the therapeutic strategy of breast cancer]. Clavel B; Gest J Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702 [TBL] [Abstract][Full Text] [Related]
17. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228 [TBL] [Abstract][Full Text] [Related]
18. Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy. Takei H; Horiguchi J; Maemura M; Koibuchi Y; Oyama T; Yokoe T; Iino Y; Morishita Y Oncol Rep; 2002; 9(2):375-8. PubMed ID: 11836611 [TBL] [Abstract][Full Text] [Related]
19. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642 [TBL] [Abstract][Full Text] [Related]
20. Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. Enger SM; Ross RK; Paganini-Hill A; Carpenter CL; Bernstein L Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):681-7. PubMed ID: 10919738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]